|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26,469.95 INR | -0.81% |
|
-3.30% | -8.94% |
| 13/02 | Abbott India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 | CI |
| 12/02 | Abbott India Dec-quarter profit 3.76 billion rupees | RE |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 14.68 | 15.9 | 16.23 | 17.75 | 18.29 | |||||
Return on Total Capital | 20.22 | 22.39 | 22.72 | 24.43 | 24.75 | |||||
Return On Equity % | 27.44 | 29.46 | 31.6 | 34.88 | 35.66 | |||||
Return on Common Equity | 27.44 | 29.46 | 31.6 | 34.88 | 35.66 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 44.31 | 45.77 | 44.17 | 44.73 | 45.23 | |||||
SG&A Margin | 14.21 | 14.95 | 12.82 | 11.81 | 10.77 | |||||
EBITDA Margin % | 20.52 | 21.3 | 21.79 | 24.13 | 25.83 | |||||
EBITA Margin % | 20.13 | 20.87 | 21.33 | 23.68 | 25.4 | |||||
EBIT Margin % | 20.12 | 20.85 | 21.32 | 23.67 | 25.37 | |||||
Income From Continuing Operations Margin % | 16.03 | 16.24 | 17.75 | 20.54 | 22.07 | |||||
Net Income Margin % | 16.03 | 16.24 | 17.75 | 20.54 | 22.07 | |||||
Net Avail. For Common Margin % | 16.03 | 16.24 | 17.75 | 20.54 | 22.07 | |||||
Normalized Net Income Margin | 13.43 | 13.72 | 14.8 | 17.08 | 18.26 | |||||
Levered Free Cash Flow Margin | 14.18 | 16.32 | 14.36 | 17.22 | 9.23 | |||||
Unlevered Free Cash Flow Margin | 14.4 | 16.51 | 14.51 | 17.32 | 9.3 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.17 | 1.22 | 1.22 | 1.2 | 1.15 | |||||
Fixed Assets Turnover | 16.55 | 19.17 | 21.56 | 25.35 | 22.25 | |||||
Receivables Turnover (Average Receivables) | 15.17 | 18.27 | 17.68 | 18.34 | 18.33 | |||||
Inventory Turnover (Average Inventory) | 3.86 | 3.8 | 4.47 | 5.1 | 4.68 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.41 | 3.2 | 2.51 | 2.42 | 3.39 | |||||
Quick Ratio | 2.68 | 2.6 | 1.94 | 1.91 | 2.71 | |||||
Operating Cash Flow to Current Liabilities | 0.7 | 0.79 | 0.74 | 0.9 | 0.72 | |||||
Days Sales Outstanding (Average Receivables) | 24.06 | 19.97 | 20.65 | 19.96 | 19.91 | |||||
Days Outstanding Inventory (Average Inventory) | 94.64 | 96.14 | 81.69 | 71.8 | 78.07 | |||||
Average Days Payable Outstanding | 100.06 | 114.29 | 110.32 | 108.24 | 99.68 | |||||
Cash Conversion Cycle (Average Days) | 18.64 | 1.82 | -7.98 | -16.47 | -1.69 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 5.86 | 5.38 | 3.55 | 2.25 | 4.65 | |||||
Total Debt / Total Capital | 5.54 | 5.1 | 3.43 | 2.2 | 4.44 | |||||
LT Debt/Equity | 4.52 | 3.86 | 2.12 | 0.99 | 3.73 | |||||
Long-Term Debt / Total Capital | 4.27 | 3.66 | 2.04 | 0.97 | 3.56 | |||||
Total Liabilities / Total Assets | 32.24 | 33.25 | 30.01 | 28.78 | 28.46 | |||||
EBIT / Interest Expense | 56.84 | 66.52 | 93.16 | 155.91 | 229.03 | |||||
EBITDA / Interest Expense | 60.54 | 70.78 | 98.84 | 163.88 | 239.11 | |||||
(EBITDA - Capex) / Interest Expense | 59.02 | 67.93 | 96.06 | 158.44 | 231.7 | |||||
Total Debt / EBITDA | 0.17 | 0.14 | 0.09 | 0.06 | 0.12 | |||||
Net Debt / EBITDA | -2.43 | -2.37 | -1.5 | -1.4 | -1.72 | |||||
Total Debt / (EBITDA - Capex) | 0.17 | 0.14 | 0.1 | 0.06 | 0.12 | |||||
Net Debt / (EBITDA - Capex) | -2.5 | -2.47 | -1.54 | -1.45 | -1.77 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 5.3 | 14.14 | 8.86 | 9.35 | 9.58 | |||||
Gross Profit, 1 Yr. Growth % | 8.02 | 17.89 | 5.22 | 10.73 | 10.81 | |||||
EBITDA, 1 Yr. Growth % | 22.54 | 18.45 | 11.89 | 21.17 | 17.27 | |||||
EBITA, 1 Yr. Growth % | 22.94 | 18.34 | 11.81 | 21.45 | 17.51 | |||||
EBIT, 1 Yr. Growth % | 22.94 | 18.27 | 11.81 | 21.47 | 17.45 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 16.49 | 15.64 | 18.87 | 26.52 | 17.75 | |||||
Net Income, 1 Yr. Growth % | 16.49 | 15.64 | 18.87 | 26.52 | 17.75 | |||||
Normalized Net Income, 1 Yr. Growth % | 15.31 | 16.58 | 17.8 | 26.23 | 17.37 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 16.49 | 15.64 | 18.87 | 26.52 | 17.75 | |||||
Accounts Receivable, 1 Yr. Growth % | -21.3 | 15.17 | 9.99 | 0.1 | 19.15 | |||||
Inventory, 1 Yr. Growth % | 36.12 | -4.15 | -5.67 | -4.51 | 42.36 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -7.5 | 5.1 | -11.4 | -2 | 52.2 | |||||
Total Assets, 1 Yr. Growth % | 8.28 | 9.99 | 7.85 | 14 | 13.94 | |||||
Tangible Book Value, 1 Yr. Growth % | 7 | 8.08 | 13.16 | 16.07 | 14.48 | |||||
Common Equity, 1 Yr. Growth % | 7.01 | 8.36 | 13.08 | 16.01 | 14.44 | |||||
Cash From Operations, 1 Yr. Growth % | 16.07 | 30.4 | -5.73 | 35.75 | -16.57 | |||||
Capital Expenditures, 1 Yr. Growth % | 48.09 | 89.06 | -22.6 | 41.69 | 8.84 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 9.94 | 25.32 | -3.84 | 31.17 | -41.3 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 10.89 | 24.96 | -4.04 | 30.6 | -41.19 | |||||
Dividend Per Share, 1 Yr. Growth % | 12.15 | 20.83 | 24.14 | 127.78 | 15.85 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.24 | 9.63 | 11.4 | 9.11 | 9.46 | |||||
Gross Profit, 2 Yr. CAGR % | 9.9 | 12.84 | 11.23 | 7.94 | 10.77 | |||||
EBITDA, 2 Yr. CAGR % | 20.59 | 20.48 | 14.8 | 16.41 | 19.2 | |||||
EBITA, 2 Yr. CAGR % | 21.01 | 20.62 | 14.69 | 16.5 | 19.46 | |||||
EBIT, 2 Yr. CAGR % | 21.02 | 20.58 | 14.66 | 16.51 | 19.45 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 23.84 | 16.06 | 17.24 | 22.64 | 22.06 | |||||
Net Income, 2 Yr. CAGR % | 23.84 | 16.06 | 17.24 | 22.64 | 22.06 | |||||
Normalized Net Income, 2 Yr. CAGR % | 15.92 | 15.94 | 16.93 | 21.92 | 21.61 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 23.84 | 16.06 | 17.24 | 22.64 | 22.06 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.81 | -4.79 | 12.55 | 5.23 | 9.21 | |||||
Inventory, 2 Yr. CAGR % | 8.75 | 14.23 | -4.91 | -5.09 | 16.59 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 55.25 | -1.4 | -3.5 | -6.82 | 22.13 | |||||
Total Assets, 2 Yr. CAGR % | 14.27 | 9.13 | 8.91 | 10.88 | 13.97 | |||||
Tangible Book Value, 2 Yr. CAGR % | 13.85 | 7.54 | 10.59 | 14.6 | 15.27 | |||||
Common Equity, 2 Yr. CAGR % | 13.82 | 7.68 | 10.7 | 14.53 | 15.22 | |||||
Cash From Operations, 2 Yr. CAGR % | 20.67 | 23.03 | 10.87 | 13.13 | 6.42 | |||||
Capital Expenditures, 2 Yr. CAGR % | 37.59 | 67.33 | 20.97 | 4.72 | 24.18 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -8.6 | 20.16 | 9.52 | 12.28 | -12.25 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -7.9 | 20.46 | 9.25 | 11.92 | -12.36 | |||||
Dividend Per Share, 2 Yr. CAGR % | 54.92 | 16.41 | 22.47 | 68.15 | 62.45 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 9.33 | 10.17 | 9.33 | 10.71 | 9.26 | |||||
Gross Profit, 3 Yr. CAGR % | 11.27 | 12.5 | 10.15 | 11.06 | 8.89 | |||||
EBITDA, 3 Yr. CAGR % | 18.7 | 19.87 | 17.32 | 16.87 | 16.7 | |||||
EBITA, 3 Yr. CAGR % | 19.04 | 20.11 | 17.38 | 16.88 | 16.84 | |||||
EBIT, 3 Yr. CAGR % | 19.08 | 20.09 | 17.36 | 16.87 | 16.83 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 19.85 | 21.05 | 16.99 | 20.26 | 20.99 | |||||
Net Income, 3 Yr. CAGR % | 19.85 | 21.05 | 16.99 | 20.26 | 20.99 | |||||
Normalized Net Income, 3 Yr. CAGR % | 14.21 | 16.14 | 16.39 | 19.94 | 20.31 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 19.85 | 21.05 | 16.99 | 20.26 | 20.99 | |||||
Accounts Receivable, 3 Yr. CAGR % | -1.7 | 1.43 | -0.1 | 8.45 | 9.68 | |||||
Inventory, 3 Yr. CAGR % | 7.03 | 4.27 | 7.17 | -4.78 | 8.64 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 45.8 | 36.32 | -4.85 | -3 | 9.74 | |||||
Total Assets, 3 Yr. CAGR % | 16.7 | 12.83 | 8.7 | 10.58 | 11.89 | |||||
Tangible Book Value, 3 Yr. CAGR % | 15.46 | 11.89 | 9.38 | 12.39 | 14.56 | |||||
Common Equity, 3 Yr. CAGR % | 15.41 | 11.97 | 9.45 | 12.44 | 14.5 | |||||
Cash From Operations, 3 Yr. CAGR % | 68.21 | 23.83 | 12.58 | 18.61 | 2.21 | |||||
Capital Expenditures, 3 Yr. CAGR % | 11.66 | 52.96 | 29.41 | 27.51 | 6.08 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 197.3 | 3.14 | 11.38 | 16.29 | -9.55 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 204.01 | 3.54 | 11.49 | 15.93 | -9.68 | |||||
Dividend Per Share, 3 Yr. CAGR % | 33.89 | 42.6 | 18.93 | 50.61 | 48.52 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 10.51 | 11.13 | 10.15 | 9.72 | 9.38 | |||||
Gross Profit, 5 Yr. CAGR % | 11.37 | 13.74 | 11.25 | 10.6 | 10.4 | |||||
EBITDA, 5 Yr. CAGR % | 19.24 | 21.17 | 17.13 | 18.34 | 18.06 | |||||
EBITA, 5 Yr. CAGR % | 19.66 | 21.61 | 17.28 | 18.52 | 18.2 | |||||
EBIT, 5 Yr. CAGR % | 19.66 | 21.59 | 17.29 | 18.51 | 18.18 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 22.03 | 23.62 | 18.8 | 21.68 | 18.99 | |||||
Net Income, 5 Yr. CAGR % | 22.03 | 23.62 | 18.8 | 21.68 | 18.99 | |||||
Normalized Net Income, 5 Yr. CAGR % | 18.39 | 19.85 | 15.29 | 18.32 | 18.44 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 22.03 | 23.62 | 18.8 | 21.68 | 18.99 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.08 | 10.34 | 3.77 | 2.94 | 3.64 | |||||
Inventory, 5 Yr. CAGR % | 14.16 | 6.56 | 2.08 | 0.42 | 10.84 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 18.35 | 18.45 | 23.61 | 17.07 | 5.14 | |||||
Total Assets, 5 Yr. CAGR % | 18.89 | 15.38 | 13.52 | 12.05 | 10.78 | |||||
Tangible Book Value, 5 Yr. CAGR % | 16.89 | 15.23 | 13.48 | 12.97 | 11.7 | |||||
Common Equity, 5 Yr. CAGR % | 16.83 | 15.25 | 13.5 | 12.99 | 11.73 | |||||
Cash From Operations, 5 Yr. CAGR % | 23.92 | 25.27 | 42.38 | 19.43 | 10.08 | |||||
Capital Expenditures, 5 Yr. CAGR % | 0.51 | 16.36 | 15.29 | 31.45 | 27.29 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 29.07 | 21.89 | 101.27 | 6.6 | 1.24 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 29.39 | 22.18 | 103.75 | 6.72 | 1.25 | |||||
Dividend Per Share, 5 Yr. CAGR % | 27.94 | 29.38 | 29.2 | 52.32 | 34.73 |
- Stock Market
- Equities
- ABBOTINDIA Stock
- Financials Abbott India Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















